Sachin Gopalkrishna Pai
Overview
Explore the profile of Sachin Gopalkrishna Pai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagasaka M, Singh V, Baca Y, Sukari A, Kim C, Mamdani H, et al.
Clin Lung Cancer
. 2021 Nov;
23(1):52-59.
PMID: 34801409
Background: HER2 alteration (mutation and/or amplification) is associated with poor survival in NSCLC and can mediate resistance to EGFR tyrosine kinase inhibitors. Methods: We retrospectively analyzed de-identified molecular information from...
2.
Judd J, Karim N, Khan H, Naqash A, Baca Y, Xiu J, et al.
Mol Cancer Ther
. 2021 Sep;
20(12):2577-2584.
PMID: 34518295
is the most commonly mutated oncogene in NSCLC and development of direct KRAS inhibitors has renewed interest in this molecular variant. Different mutations may represent a unique biologic context with...
3.
Pai S, Carneiro B, Mota J, Costa R, Leite C, Barroso-Sousa R, et al.
J Hematol Oncol
. 2017 May;
10(1):101.
PMID: 28476164
Wnt/β-catenin signaling, a highly conserved pathway through evolution, regulates key cellular functions including proliferation, differentiation, migration, genetic stability, apoptosis, and stem cell renewal. The Wnt pathway mediates biological processes by...
4.
Pai S, Kaplan J, Giles F
Expert Rev Hematol
. 2016 Sep;
9(10):915-7.
PMID: 27584865
No abstract available.
5.
Chae Y, Gagliato D, Pai S, Carneiro B, Mohindra N, Giles F, et al.
PLoS One
. 2016 Apr;
11(4):e0152585.
PMID: 27055285
EGFR and cMET cross-talk is involved in breast cancer (BC) progression and resistance to different targeted therapies, however little is known about the co-expression patterns of EGFR and cMET or...
6.
Pai S, Fuloria J
World J Gastrointest Oncol
. 2016 Jan;
8(1):99-104.
PMID: 26798440
Over the past couple of decades considerable progress has been made in the management of metastatic colorectal cancers (mCRC) leading to a significant improvement in five-year survival. Although part of...